70 Hospitals and Health Systems With Great Oncology Programs

Becker's Hospital Review has named "70 Hospitals and Health Systems With Great Oncology Programs." These hospitals are on the cutting edge of cancer treatment, prevention and research, and the Becker's Hospital Review editorial team selected them based on clinical accolades, quality care and contributions to the field of oncology.

These hospitals have been recognized for excellence in this specialty by reputable healthcare rating resources, including U.S. News & World Report, HealthGrades, Thomson Reuters, the National Cancer Institute, the American College of Surgeons and the American Nurses Credentialing Center. They have demonstrated continual innovation in treatments and services, patient-centered care and the achievement of clinical milestones and groundbreaking discoveries.

Note: This list is not an endorsement of included hospitals or associated healthcare providers, and hospitals cannot pay to be included on this list. The following content should be used for informational purposes only and is not intended to substitute professional medical advice. Hospitals are presented in alphabetical order.

Atlantic Health Carol G. Simon Cancer Center (Morristown and Summit, N.J.). Atlantic Health System is a major clinical research affiliate of the Cancer Institute of New Jersey, which includes 16 hospitals across the state. It is one of the only hospitals in the region to offer the Prostate Navigate Program — a patient-centered, multidisciplinary consultation service that helps patients select their preferred method of prostate cancer treatment. The center has received the American College of Surgeons Outstanding Achievement Award for cancer care, which is awarded to less than 15 percent of hospitals in the country.

Barnes-Jewish Hospital (St. Louis). The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine was named a Comprehensive Cancer Center by the National Cancer Institute in 2005. Siteman offers approximately 250 clinical trials for patients, and more than 150 families visit the center's hereditary cancer program each year, which helps people with a family history of cancer assess their risk. In August, Siteman celebrated its 5,000th bone marrow transplant since 1982.

Dan L. Duncan Cancer Center at Baylor College of Medicine (Houston).
The Dan L. Duncan Cancer Center at Baylor College of Medicine is a consortium made up of Baylor College of Medicine and its three primary teaching hospital affiliates — Ben Taub General Hospital, Michael E. DeBakey Veterans Affairs Medical Center and Texas Children's Hospital. It's one of three cancer centers in Texas recognized by the National Cancer Institute. With an office of outreach and disparities, Baylor works to enhance the enrollment of under-represented minorities in clinical trials and to reduce disparities in cancer care.

Beth Israel Deaconess Medical Center (Boston). The Cancer Center at Beth Israel Deaconess Medical Center includes 19 specialty programs in oncology along with eight multidisciplinary clinics that use a team-based approach. It is one of only 34 centers in the country to receive the Outstanding Achievement Award from the American College of Surgeons Commission on Cancer. BIDMC's Pier Paolo Pandolfi, MD, PhD, received the 2011 International Award for Cancer Research from the Pezcoller Foundation-American Association of Cancer Research for the advancements he made in cancer genetics.

Carolinas Medical Center (Charlotte, N.C.). The Blumenthal Cancer Center is nationally accredited by the American College of Surgeons and received the Outstanding Achievement Award from the American College of Surgeons Commission on Cancer in May. The cancer program of Carolinas Medical Center is now organized within the Levine Cancer Institute, an entity Carolinas Healthcare System formed in 2010 to combine cancer programs across its hospitals. It is headquartered on the Carolinas Medical Center campus, and the facility is expected to open in fall 2012.

Cedars Sinai Medical Center (Los Angeles). The Samuel Oschin Comprehensive Cancer Institute at Cedars Sinai offers multidisciplinary teams, with many of the center's physicians being published authors and prominent researchers in oncology. The center uses disease-specific tumor boards to help patients design their treatment plans. Cedars Sinai includes a 24-hour outpatient cancer center, which sees more than 9,000 patients each year. The center is home to basic and clinical oncology research along with clinical trials. It recently partnered with a research institute in Arizona to offer joint clinical trials for new anti-cancer therapies aimed at molecular cancer targets.

City of Hope Comprehensive Cancer Center (Duarte, Calif.). City of Hope was founded in 1913 and has performed more than 10,000 bone marrow and stem cell transplants, making it one of the largest such programs in the world. More than 3,000 clinical trials are held at City of Hope at any given time, and roughly 40 percent of patients participate in them — compared with a national average of less than 5 percent. City of Hope is currently the only institution in the world to hold clinical studies with genetically engineered T-cells to recognize glioma, a terminal form of brain cancer.

Cleveland Clinic (Cleveland). With a focus on the patient experience, patients visiting the Taussig Cancer Institute at Cleveland Clinic can participate in support groups, art therapy and even high tea as a pleasant diversion from their rounds of treatment. Taussig is a partner with Case Comprehensive Cancer Center in Cleveland, which is a National Cancer Institute-designated Comprehensive Cancer Center. In May, Cleveland Clinic researchers made strides in the first-of-its-kind vaccine to prevent breast cancer, a groundbreaking development in oncology. Enrollment in human trials for that vaccine may begin in 2012.

Dana-Farber Cancer Institute (Boston). Dana-Farber, which was founded in 1947, collaborates with Brigham and Women's Hospital for oncology services and is a teaching hospital affiliated with Harvard Medical School. It recently opened its Yawkey Center for Cancer Care, a new 14-story facility with 104 exam rooms and 139 infusion chairs — a 30 percent increase from the current capacity on Dana-Farber's main campus. Dana-Farber's clinical reach is quite extensive: It sees more than 300,000 patient visits each year and offers roughly 700 clinical trials. Dana-Farber is a Comprehensive Cancer Center as designated by the National Cancer Institute.

Dartmouth-Hitchcock Medical Center (Lebonon, N.H.). The Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center includes more than 200 oncologists and 135 research investigators and offers at least 100 clinical trials to patients at any one time. Multidisciplinary teams develop treatment plans individually for each of the 31,000 patients that visit Dartmouth for oncology services each year. In October, the center earned a five-year, $6.1 million grant from the National Cancer Institute for research at its breast cancer screening center — one of three such facilities in the nation.

Duke University Hospital (Durham, N.C.).
Duke Cancer Institute serves nearly 6,000 new cancer patients each year and has clinical research partnerships in India, China, Singapore and throughout the United States. It is a comprehensive cancer center as designated by the National Cancer Institute and is also part of the National Comprehensive Cancer Network, which is comprised of 21 cancer centers across the country. The center is home to more than 300 researchers and oncologists. Duke scientists recently found a protein in breast cancer cells that may fuel aggressive tumors and could make an effective target for new drugs.

Emory University Hospital (Atlanta). Emory's Winship Cancer Institute is the only National Cancer Institute-designated cancer center in the state of Georgia. It was founded in 1937 through a donation from the then-president of Coca-Cola, Robert Woodruff, who lost his mother to cancer that same year. The center takes a multidisciplinary approach to cancer treatment and teams of experts meet every day to plan the most advanced care for patients. In 2011, it partnered with Advance Particle Therapy to develop the Georgia Proton Therapy Center — the state's first proton therapy facility.

Fox Chase Cancer Center (Philadelphia).
Fox Chase was founded in 1974 and was designated by the National Cancer Institute as a Comprehensive Cancer Center that same year. In a move reflecting its transparency, Fox Chase recently became one of the first cancer centers in the country to publish its clinical outcomes for breast, colorectal, lung and prostate cancer. In nearly all five categories, the outcomes are better compared to those of large and small community hospital cancer programs. Scientists at Fox Chase have cataloged and cross-indexed the actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical for cancer.

Froedtert Hospital (Milwaukee). Froedtert Hospital's Clinical Cancer Center includes more than 200 oncologists, physicians and scientists in 13 disease-specific cancer programs. The center operates under a patient-centered "hub model," where physicians are grouped by the kinds of cancer they treat, not the type of service they provide. It was recognized as a regional leader in cancer care in U.S. News & World Report's 2011 Best Hospitals list. The hospital, which uses tumor boards to develop patient-specific treatment plans, is also part of a cancer care network with two other local hospitals.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Whitepapers

Featured Webinars